Preclinical medicine and high-throughput biology consultant
NCATS
Jayme Dahlin is currently a preclinical medicine and high-throughput biology consultant at the National Center for Advancing Translational Sciences (NCATS). Dr. Dahlin serves in the Office of Translational Medicine where he provides medical direction to various NCATS projects. He also serves as the high-throughput biology lead for the NCATS ASPIRE Initiative which seeks to integrate advances in automated chemistry, high-throughput biology, and AI/ML to more rapidly explore chemical space in preclinical drug discovery.